KUALA LUMPUR, March 5 (Bernama) -- ImmunoScape Pte Ltd, a clinical-stage biotechnology company, has announced the execution of a memorandum of understanding (MoU) with a premier National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the United States (US).